Format
Sort by
Items per page

Send to

Choose Destination

Links from MedGen

Items: 1 to 20 of 585

1.

Dyskeratosis Congenita with Adenocarcinoma of Stomach.

Singh RP, Tiwari VD, Misuriya AK, Chattopadhyay SP.

Indian J Dermatol Venereol Leprol. 1989 Nov-Dec;55(6):391-392.

2.

Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.

Imai J, Suzuki T, Yoshikawa M, Dekiden M, Nakae H, Nakahara F, Tsuda S, Mizukami H, Koike J, Igarashi M, Yabe H, Mine T.

Intern Med. 2016;55(23):3441-3444.

3.

Diffuse Mesangial Sclerosis in a Child With Dyskeratosis Congenita Leading to End-stage Renal Disease.

Kamel A, Sayari T, Jellouli M, Hammi Y, Louzir RG, Gargah T.

Iran J Kidney Dis. 2016 Nov;10(6):416-418.

4.

RETINAL VASCULAR TORTUOSITY AND EXUDATIVE RETINOPATHY IN A FAMILY WITH DYSKERATOSIS CONGENITA MASQUERADING AS FAMILIAL EXUDATIVE VITREORETINOPATHY.

Thanos A, Todorich B, Hypes SM, Yonekawa Y, Thomas B, Randhawa S, Drenser KA, Trese MT.

Retin Cases Brief Rep. 2017 Winter;11 Suppl 1:S187-S190. doi: 10.1097/ICB.0000000000000430.

PMID:
27685501
5.

Clonal hematopoiesis in patients with dyskeratosis congenita.

Perdigones N, Perin JC, Schiano I, Nicholas P, Biegel JA, Mason PJ, Babushok DV, Bessler M.

Am J Hematol. 2016 Dec;91(12):1227-1233. doi: 10.1002/ajh.24552.

PMID:
27622320
6.

Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.

Walne AJ, Collopy L, Cardoso S, Ellison A, Plagnol V, Albayrak C, Albayrak D, Kilic SS, Patıroglu T, Akar H, Godfrey K, Carter T, Marafie M, Vora A, Sundin M, Vulliamy T, Tummala H, Dokal I.

Haematologica. 2016 Oct;101(10):1180-1189.

7.

Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.

Elmahadi S, Muramatsu H, Kojima S.

Curr Opin Hematol. 2016 Nov;23(6):501-507.

PMID:
27607446
8.

Dyskeratosis congenita presenting with dysphagia.

Gupta K, Tripathi S, Agarwal N, Bareth A.

Indian Dermatol Online J. 2016 Jul-Aug;7(4):275-7. doi: 10.4103/2229-5178.185461.

9.

Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in a Human Organotypic Model of Dyskeratosis Congenita.

Woo DH, Chen Q, Yang TL, Glineburg MR, Hoge C, Leu NA, Johnson FB, Lengner CJ.

Cell Stem Cell. 2016 Sep 1;19(3):397-405. doi: 10.1016/j.stem.2016.05.024.

PMID:
27545506
10.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA.

Mol Genet Genomic Med. 2016 Mar 20;4(4):475-9. doi: 10.1002/mgg3.220.

11.

Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation.

Lal M, Thakur M, Kashyap S.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):228-32. doi: 10.1007/s12288-015-0511-8.

PMID:
27408398
12.

DYSKERATOSIS CONGENITA IN TWO ETHIOPIAN BROTHERS.

Gebremedhin A, Bekele A.

Ethiop Med J. 2015 Oct;53(4):215-21.

PMID:
27182588
13.

Bilateral Proliferative Retinopathy Associated With Hoyeraal-Hreidarsson Syndrome, a Severe Form of Dyskeratosis Congenita.

Allingham MJ.

Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 1;47(4):366-8. doi: 10.3928/23258160-20160324-11.

14.

Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report.

Zheng XY, Xu J, Li W, Li SS, Shi CP, Zhao ZY, Mao JH, Chen X.

Medicine (Baltimore). 2016 Mar;95(12):e3106. doi: 10.1097/MD.0000000000003106.

15.

Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.

Barbaro P, Vedi A.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1152-8. doi: 10.1016/j.bbmt.2016.03.001. Review.

PMID:
26968789
16.

DNA methylation in PRDM8 is indicative for dyskeratosis congenita.

Weidner CI, Lin Q, Birkhofer C, Gerstenmaier U, Kaifie A, Kirschner M, Bruns H, Balabanov S, Trummer A, Stockklausner C, Höchsmann B, Schrezenmeier H, Wlodarski M, Panse J, Brümmendorf TH, Beier F, Wagner W.

Oncotarget. 2016 Mar 8;7(10):10765-72. doi: 10.18632/oncotarget.7458.

17.

Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First.

Mahansaria SS, Kumar S, Bharathy KG, Kumar S, Pamecha V.

J Clin Exp Hepatol. 2015 Dec;5(4):344-7. doi: 10.1016/j.jceh.2015.10.003.

18.

Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.

Pereboeva L, Hubbard M, Goldman FD, Westin ER.

PLoS One. 2016 Feb 9;11(2):e0148793. doi: 10.1371/journal.pone.0148793.

19.

A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

Nelson AS, Marsh RA, Myers KC, Davies SM, Jodele S, O'Brien TA, Mehta PA.

Biol Blood Marrow Transplant. 2016 May;22(5):884-8. doi: 10.1016/j.bbmt.2016.01.026.

PMID:
26845033
20.

Dyskeratosis congenita associated with leukoplakia of the tongue.

Noto Z, Tomihara K, Furukawa K, Noguchi M.

Int J Oral Maxillofac Surg. 2016 Jun;45(6):760-3. doi: 10.1016/j.ijom.2015.12.005.

PMID:
26778687

Supplemental Content

Support Center